Home - Products - Others - Other Targets - 7-Methoxy-1-naphthaleneacetic acid

7-Methoxy-1-naphthaleneacetic acid

CAS No. 6836-22-2

7-Methoxy-1-naphthaleneacetic acid( —— )

Catalog No. M28962 CAS No. 6836-22-2

7-Methoxy-1-naphthaleneacetic acid is an inhibitor of auxin action in plants.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    7-Methoxy-1-naphthaleneacetic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Methoxy-1-naphthaleneacetic acid is an inhibitor of auxin action in plants.
  • Description
    7-Methoxy-1-naphthaleneacetic acid is an inhibitor of auxin action in plants. 7-Methoxy-1-naphthaleneacetic acid inhibits polar auxin transport and tropic responses associated with asymmetric auxin distribution in Arabidopsis and maize. 7-Methoxy-1-naphthaleneacetic acid inhibits auxin transport mediated by AUX1, PIN, and ABCB proteins expressed in yeast.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    JAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6836-22-2
  • Formula Weight
    216.236
  • Molecular Formula
    C13H12O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc2cccc(CC(O)=O)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Daniel Magilavy, et al. 2,4 substituted pyrimidinediamines for use in discoid lupus. WO2012122452A1.
molnova catalog
related products
  • Emoxypine Succinate

    Emoxypine Succinate is an antioxidant.?

  • WR-99210

    WR-99210 is a potent inhibitor of?Plasmodium falciparum?dihydrofolate reductase (pfDHFR), which is a major malarial drug target.

  • [Pro3]-GIP (Mouse)

    GIP receptor antagonist (IC50 = 2.6μM). Inhibits GIP-stimulated insulin release from pancreatic β cells in vitro. In ob/ob mice, blocks the effects of GIP on insulin release and plasma glucose levels. Also improves intraperitoneal glucose tolerance, insulin sensitivity, and glucose response to feeding in ob/ob mice.